Skip to main content
Article thumbnail
Location of Repository

The ubiquitously expressed bZIP inhibitor, JDP2, suppresses the transcription of its homologue immediate early gene counterpart, ATF3

By Keren Weidenfeld-Baranboim, Tal Hasin, Ilona Darlyuk, Ronit Heinrich, Ofer Elhanani, Jianzhi Pan, Kazunari K. Yokoyama and Ami Aronheim

Abstract

JDP2 is a ubiquitously expressed bZIP repressor protein. JDP2 binds TPA response element and cyclic AMP response element located within various promoters. JDP2 displays a high degree of homology to the immediate early gene ATF3. ATF3 plays a crucial role in the cellular adaptive response to multiple stress insults as well as growth stimuli. We have identified ATF3 as a potential target gene for JDP2 repression. JDP2 regulates the ATF3 promoter potentially through binding to both the consensus ATF/CRE site and a non-consensus ATF3 auto-repression DNA-binding element. Expression of ATF3 protein in wild-type mouse embryo fibroblast (MEF) cells is below the detectable levels, whereas, JDP2 disrupted MEF cells display noticeable level of ATF3 protein. Following either serum or ER stress stimulation, ATF3 expression is potentiated in JDP2-KO fibroblast cells as compared with wild-type cells. Mice with either JDP2 over-expression or JDP2 disruption display undetectable level of ATF3 protein. However, ATF3 induction in response to either growth or stress signals is dependent on JDP2 expression level. ATF3 induction is attenuated in JDP2 over-expressing mice whereas is potentiated in JDP2-KO mice as compared with the corresponding wild-type mice. Collectively, the data presented strongly suggest that JDP2 plays a role in the determination of the ATF3 adaptive cellular threshold response to different stress insults and growth stimuli

Topics: Gene Regulation, Chromatin and Epigenetics
Publisher: Oxford University Press
OAI identifier: oai:pubmedcentral.nih.gov:2673429
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2008). A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development.
    2. (2006). Activating transcription factor 3 and early growth response 1 are the novel targets of LY294002 in a phosphatidylinositol 3-kinase-independent pathway.
    3. (2006). Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis.
    4. (2004). Animal models of liver regeneration.
    5. (2001). AP-1 repressor protein JDP-2: inhibition of UV-mediated apoptosis through p53 down-regulation.
    6. (2006). Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3), which promotes viability of Hodgkin/Reed-Sternberg cells.
    7. (1991). Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity.
    8. (2002). Differential targeting of the stress mitogen-activated protein kinases to the c-Jun dimerization protein
    9. (1996). Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.
    10. (2005). Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin.
    11. (2001). Identification of mouse Jun dimerization protein 2 as a novel repressor of ATF-2.
    12. (2002). Identification of oncogenes collaborating with p27Kip1 loss by insertional mutagenesis and high-throughput insertion site analysis.
    13. (2002). Induction of terminal differentiation by the c-Jun dimerization protein JDP2 in C2 myoblasts and rhabdomyosarcoma cells.
    14. (2006). Inhibition of basic leucine zipper transcription is a major mediator of atrial dilatation.
    15. (2007). Insertional mutagenesis reveals progression genes and checkpoints in MYC/Runx2 lymphomas.
    16. (2008). IRF2-binding protein-1 is a JDP2 ubiquitin ligase and an inhibitor of ATF2-dependent transcription.
    17. (1997). Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions.
    18. (2007). JDP2 suppresses adipocyte differentiation by regulating histone acetylation.
    19. (2002). JDP2, a repressor of AP-1, recruits a histone deacetylase 3 complex to inhibit the retinoic acid-induced differentiation of F9 cells.
    20. (2003). Jun dimerization protein 2 (JDP2), a member of the AP-1 family of transcription factor, mediates osteoclast differentiation induced by RANKL.
    21. (2006). Profiles of growth hormone (GH)-regulated genes reveal time-dependent responses and identify a mechanism for regulation of activating transcription factor 3 by GH.
    22. (2006). Regulation of histone acetylation and nucleosome assembly by transcription factor JDP2.
    23. (2008). Role of the repressor JDP2 in the amino acid-regulated transcription of CHOP.
    24. (2005). Stress response gene ATF3 is a target of c-myc in serum-induced cell proliferation.
    25. (2001). The AP-1 repressor, JDP2, is a bona fide substrate for the c-Jun N- terminal kinase.
    26. (2006). The ATF Transcription Factors in Cellular Adaptive Responses.
    27. (2004). The c-Jun Dimerization Protein 2 Inhibits Cell Transformation and Acts as a Tumor Suppressor Gene.
    28. (1998). The Ras recruitment system, a novel approach to the study of protein-protein interactions.
    29. (2007). The regulation of ATF3 gene expression by mitogen-activated protein kinases.
    30. (2006). The role of basic leucine zipper protein-mediated transcription in physiological and pathological myocardial hypertrophy.
    31. (2000). Transcriptional autorepression of the stress-inducible gene ATF3.
    32. (2008). TRE-dependent transcription activation by JDP2-CHOP10 association.
    33. (2005). Tumor model-specific proviral insertional mutagenesis of the Fos/Jdp2/Batf locus.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.